Exploring biomarkers to predict clinical improvement of Atopic Dermatitis in patients treated with dupilumab (B-PAD study)

Takeshi Nakahara

doi:10.5281/zenodo.7317336

Published November 14, 2022 | Version v1

Journal article Open

Exploring biomarkers to predict clinical improvement of Atopic Dermatitis in patients treated with dupilumab (B-PAD study)

Takeshi Nakahara¹

1. Kyushu University

This is a exploratory study to explore the predictive biomarkers that are associated with clinical improvement in patients with moderate to severe AD treated with dupilumab.

Files

Files (89.6 kB)

Name	Size	Download all
2022 B-PAD RL sup material for CEA.docx md5:bdfa112cd335448a60de9be4a5f5e1af	89.6 kB	Download

561

Views

172

Downloads

Show more details

	All versions	This version
Views	561	558
Downloads	172	170
Data volume	15.9 MB	15.7 MB

More info on how stats are collected....

DOI

Resource type

Journal article

Publisher

Zenodo

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more

Technical metadata

Created: November 13, 2022
Modified: November 14, 2022

Exploring biomarkers to predict clinical improvement of Atopic Dermatitis in patients treated with dupilumab (B-PAD study)

Creators

Description

Files

Files (89.6 kB)